Kristie Bobolis, MD is a research investigator with the Sutter Roseville Medical Center
Sutter Health Research Enterprise
8 Medical Plaza
Suite 300
Roseville, CA, 95661
(916) 782-5106
bobolik@sutterhealth.org
Related Clinical Trials
Adjuvant (Alliance A011801 Compass HER2 Residual Disease)
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial
Investigator: Kristie A. Bobolis M.D.
Status: Active, Not Recruiting
Adjuvant (NRG-BR009)
Evaluating the Addition of Adj Chemo to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients
Investigator: Kristie A. Bobolis M.D.
Status: Active, Recruiting
City of Hope 96144 Molecular Genetics Studies of Cancer Patients and Their Relatives
The purpose of this study is to find out how genetics, biologics and behavior might contribute to
Investigators: Kristin N. Arreola M.D., Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Brian K. Kim M.D, Sivakumar Reddy M.D., Vijay Suhag M.D.
Status: Active, Recruiting
Interventional (NRG-BR007) (DEBRA)
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Investigator: Kristie A. Bobolis M.D.
Status: Active, Recruiting
Metastatic (AstraZeneca D533AC00001 MONETTE)
AstraZeneca D533AC00001 MONETTE: A Randomised, Open-Label, Phase 2 Study of Ceralasertib Monotherapy and Ceralasertib plus Durvalumab in Patients with Unresect
Investigators: Kristin N. Arreola M.D., Deepti Behl MD, Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Jaspreet K Dhillon Medical Oncologist, Dron Gauchan MD, Brian K. Kim M.D, Sivakumar Reddy M.D., Vijay Suhag M.D.
Status: Active, Not Recruiting
Neoadjuvant (SWOG S2206)
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast
Investigator: Kristie A. Bobolis M.D.
Status: Active, Recruiting
The Pathfinder 2 Study (Grail)
Evaluating the Safety and Performance of the GRAIL Multi-Cancer Early Detection Test in an Eligible Screening Population
Investigators: Roger Ang MD, Deepti Behl MD, Kristie A. Bobolis M.D., Carole Chan-You M.D., Natalia Colocci M.D., Ph.D., Natasha Fine M.D., Mohammad Hararah M.D., Aaron Kinney M.D., Charles McDonnell MD, FACR, Patrick Ogilvie M.D., Sivakumar Reddy M.D., Nitin Rohatgi MD, Barbara Spinelli M.D., Gayle Sutcliffe M.D., Edmund W. Tai M.D.
Status: Active, Not Recruiting
Research Studies
Adjuvant (Guardant Health 02-MX-003 ORACLE)
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (ORACLE)
Investigators: Kristin N. Arreola M.D., Deepti Behl MD, Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Jaspreet K Dhillon Medical Oncologist, Brian K. Kim M.D, Sivakumar Reddy M.D., Vijay Suhag M.D.
Dana Farber 13-09-259 DCIS Registry
Molecular Characterization of Breast Cancer with Duct Forming Features
Investigator: Kristie A. Bobolis M.D.